Vendor and software based variation in left atrial strain measurements: implications for clinical practice
Vlad Danaila1,2, Oliver Archer1,2, Luke Stefani1
1Department of Cardiology, Westmead Hospital, Western Sydney Local Health District, Parramatta, NSW, Australia.
The International Journal of Cardiovascular Imaging
|September 3, 2025
Summary
This study compared left atrial strain (LAS) measurements from a new tool (AFI-LA) with existing platforms. AFI-LA showed good correlation but underestimated strain, requiring vendor-specific calibration for clinical use.
Area of Science:
- Cardiology
- Medical Imaging
- Echocardiography
Background:
- Left atrial strain (LAS) is a key echocardiographic marker for left atrial function.
- Variability in LAS measurements across different software platforms hinders its widespread clinical adoption.
Purpose of the Study:
- To compare LAS measurements from a dedicated tool, AFI-LA (GE), with established left ventricular (LV)-based strain platforms (GE EchoPAC, TomTec-Arena).
- To assess the agreement, correlation, and reproducibility of LAS measurements across these different software vendors.
Main Methods:
- LAS was measured in 112 subjects (sinus rhythm and paroxysmal atrial fibrillation) using AFI-LA, GE EchoPAC (mid-myocardial and endocardial tracking), and TomTec-Arena.
- Agreement was evaluated using Bland-Altman analysis and Pearson correlation.
- Inter- and intra-observer reproducibility was assessed.
Main Results:
- AFI-LA demonstrated good correlation with GE EchoPAC and TomTec (r ≥ 0.7, p < 0.001).
- AFI-LA consistently underestimated strain values compared to GE-mid, GE-endo, and TomTec, with the smallest bias against GE-mid.
- High inter- and intra-observer reproducibility was observed for AFI-LA (r > 0.85).
Conclusions:
- AFI-LA provides LAS measurements comparable to GE mid-myocardial strain but systematically underestimates values from GE endocardial and TomTec.
- Vendor-specific calibration is necessary for AFI-LA before serial assessments or use with existing clinical thresholds.
- Further validation studies are required for standardization and broader clinical adoption of AFI-LA.


